₹ (%)
- NSE
- BSE
Overview
- BSE Code 524663
- NSE Symbol
- ISIN Demat INE994B01014
- Book Value (₹) -7.54
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 98.75
- P/E (TTM) 0.00
- EPS (TTM) 0.00
- Div Yield (%) 0.00
Performance
About Bharat Immunological & Biological Corporation Ltd
Incorporated in 1989 in Uttar Pradesh, Bharat Immunological & Biological Corporation (BIBCL) is in the business of manufacturing pharmaceutical formulations.
The company's manufacturing unit is located in Bulandshahr district, Uttar Pradesh. BIBCL manufactures oral polio vaccine (OPV) for which it has installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96.
The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has created and deployed an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US.
The Company is planning to diversify into the production of vaccines pertaining to B.C.G, Measles and Tetanus Toxide.The company has been declared a SICK company by BIFR.
| Founded | : 1989 |
| Chairman | : Y K Gupta |
| Managing Director | : Sanjay Kumar Mishra |
| Address | : BIBCOL OPV Plant Village Chola, Bulandshahr, Uttar Pradesh, 203203, |
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)